BETA DRUGS
Back to Cashflow Statement
|
BETA DRUGS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-22 Cr | ₹118 Cr | ₹9.47 Cr | ₹1.84 Cr | ₹6.90 Cr |
What is the latest Net Cash Inflow / Outflow ratio of BETA DRUGS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-22 Cr |
| Mar2025 | ₹118 Cr |
| Mar2024 | ₹9.47 Cr |
| Mar2023 | ₹1.84 Cr |
| Mar2022 | ₹6.90 Cr |
How is Net Cash Inflow / Outflow of BETA DRUGS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-22 Cr | Negative | |
| Mar2025 | ₹118 Cr | 1,150.30 | |
| Mar2024 | ₹9.47 Cr | 414.62 | |
| Mar2023 | ₹1.84 Cr | -73.33 | |
| Mar2022 | ₹6.90 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹1,847.8 Cr | -2.1% | -19% | 0.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -0.2% | -4.9% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹242,904.0 Cr | 1.3% | -2.3% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹172,213.0 Cr | -1.5% | -5.8% | 29.3% | Stock Analytics | |
| CIPLA | ₹106,138.0 Cr | 0.1% | -4.2% | -14.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,304.0 Cr | 1.9% | 5.7% | 0.4% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | -2.1% |
-19% |
0.3% |
| SENSEX | 0.9% |
-0.8% |
-10.5% |
You may also like the below Video Courses